Long-term survival of a patient with microsatellite-stable refractory colorectal cancer with regorafenib and PD-1 inhibitor sintilimab: a case report and review of literature

BACKGROUND: Colorectal cancer (CRC) is the third most prevalent cancer worldwide and poses a serious challenge for clinicians. Previous studies have shown promising results in patients with Microsatellite Stable microsatellite-stable CRC refractory to chemotherapy upon treating with (Programmed Cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yong, Zhang, Fang, Zhao, Lingdi, Fu, Xiaomin, Shang, Yiman, Gao, Quanli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542310/
https://www.ncbi.nlm.nih.gov/pubmed/34688262
http://dx.doi.org/10.1186/s12876-021-01950-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542310/
https://www.ncbi.nlm.nih.gov/pubmed/34688262
http://dx.doi.org/10.1186/s12876-021-01950-y

Ejemplares similares